Katie Cinnamon, PharmD, BCPS, BCIDP
@katiecinnamon.bsky.social
Infectious diseases 🦠 & internal medicine pharmacist 💊in Madison, WI; Antimicrobial stewardship enthusiast; 2023-2024 SIDP Stewardship Committee Chair; @NdsuPharm grad; wife; dog mom 🐾
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
Excited to share our work (just in time for URI season!) implementing order sentence favorites for URI supportive care as an effective way to reduce outpatient abx prescribing, especially in Tier 3 diagnoses. Shout out to our incredible Amb Care team for partnering to implement this intervention!
@lisaidpharmd.bsky.social et al: Supportive care order sentence implementation within EHRs paired with provider education may be an effective, low-effort, outpatient stewardship practice to reduce unnecessary antibiotic prescribing for URI. doi.org/10.1017/ash....
Impact of a multifaceted intervention including supportive care order sentence implementation on outpatient antibiotic prescribing for upper respiratory tract infections | Antimicrobial Stewardship & Healthcare Epidemiology | Cambridge Core
Impact of a multifaceted intervention including supportive care order sentence implementation on outpatient antibiotic prescribing for upper respiratory tract infections - Volume 5 Issue 1
doi.org
September 15, 2025 at 11:17 PM
Excited to share our work (just in time for URI season!) implementing order sentence favorites for URI supportive care as an effective way to reduce outpatient abx prescribing, especially in Tier 3 diagnoses. Shout out to our incredible Amb Care team for partnering to implement this intervention!
So honored to be part of this group 🙌
🆕 New in ICHE: A mixed-methods study explores bias and discrimination experienced by antimicrobial stewards
Findings highlight structural inequities and the need for improved support, recognition, and inclusion in stewardship roles.
#IDsky
📄: doi.org/10.1017/ice....
Findings highlight structural inequities and the need for improved support, recognition, and inclusion in stewardship roles.
#IDsky
📄: doi.org/10.1017/ice....
August 29, 2025 at 10:54 PM
So honored to be part of this group 🙌
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025
fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
April 12, 2025 at 2:45 PM
@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025
fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
Want to know if you can safely use linezolid or tedizolid beyond 10 to 14 days? Dr. @pharmermeg.bsky.social has the answers at #ESCMIDGlobal 2025!
Key findings: No thrombocytopenia with long-term tedizolid even in high-risk pts and minimal TCP risk with long-term linezolid in low-risk pts. 💊
Key findings: No thrombocytopenia with long-term tedizolid even in high-risk pts and minimal TCP risk with long-term linezolid in low-risk pts. 💊
April 13, 2025 at 8:32 AM
Want to know if you can safely use linezolid or tedizolid beyond 10 to 14 days? Dr. @pharmermeg.bsky.social has the answers at #ESCMIDGlobal 2025!
Key findings: No thrombocytopenia with long-term tedizolid even in high-risk pts and minimal TCP risk with long-term linezolid in low-risk pts. 💊
Key findings: No thrombocytopenia with long-term tedizolid even in high-risk pts and minimal TCP risk with long-term linezolid in low-risk pts. 💊
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
Vancomycin Taper trial presented by @dremilymcd.bsky.social #ESCMID2025. In people who get better by day 10 should we stop or give taper? Reduced recurrences by primary outcome timepoint but the KM suggests it may be just delaying rather than truly preventing recurrence? #IDSky
April 13, 2025 at 3:38 PM
Vancomycin Taper trial presented by @dremilymcd.bsky.social #ESCMID2025. In people who get better by day 10 should we stop or give taper? Reduced recurrences by primary outcome timepoint but the KM suggests it may be just delaying rather than truly preventing recurrence? #IDSky
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🚀 Learn from Dr. McCreary at #MADID2025 about developing effective collaborations between antimicrobial stewardship teams and microbiology laboratories!🔬💊✨
Register today! mad-idmembership.vfairs.com 🗓️
@erinmccreary.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Register today! mad-idmembership.vfairs.com 🗓️
@erinmccreary.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
April 8, 2025 at 1:01 PM
🚀 Learn from Dr. McCreary at #MADID2025 about developing effective collaborations between antimicrobial stewardship teams and microbiology laboratories!🔬💊✨
Register today! mad-idmembership.vfairs.com 🗓️
@erinmccreary.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Register today! mad-idmembership.vfairs.com 🗓️
@erinmccreary.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🚀 Learn from Dr. Wagner at #MADID2025 about ways to enhance efficiency of antimicrobial stewardship programs and explore interprofessional team dynamics! 💊✨
Register today! mad-idmembership.vfairs.com 🗓️
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Register today! mad-idmembership.vfairs.com 🗓️
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
April 1, 2025 at 1:00 PM
🚀 Learn from Dr. Wagner at #MADID2025 about ways to enhance efficiency of antimicrobial stewardship programs and explore interprofessional team dynamics! 💊✨
Register today! mad-idmembership.vfairs.com 🗓️
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Register today! mad-idmembership.vfairs.com 🗓️
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🔍 Missed key updates in infectious diseases? Drs. Zahra Kassamali Escobar & Jamie L. Wagner have you covered at #MADID2025! 📢
Register now! 👉 mad-idmembership.vfairs.com 🗓️
@zkepharmd.bsky.social
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Register now! 👉 mad-idmembership.vfairs.com 🗓️
@zkepharmd.bsky.social
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
March 31, 2025 at 1:01 PM
🔍 Missed key updates in infectious diseases? Drs. Zahra Kassamali Escobar & Jamie L. Wagner have you covered at #MADID2025! 📢
Register now! 👉 mad-idmembership.vfairs.com 🗓️
@zkepharmd.bsky.social
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Register now! 👉 mad-idmembership.vfairs.com 🗓️
@zkepharmd.bsky.social
@jamiewagner.bsky.social
@sidpharm.bsky.social
@sheaepi.bsky.social
@accpinfdprn.bsky.social
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
happy #InternationalWomensDay to the endless sea of incredible women out there 👑
thank you @cmicomms.bsky.social @angelahuttner.bsky.social @anniejoseph.bsky.social for the safe space for this important conversation and our allies Nav, Marc, Josh, and Thomas!
thank you @cmicomms.bsky.social @angelahuttner.bsky.social @anniejoseph.bsky.social for the safe space for this important conversation and our allies Nav, Marc, Josh, and Thomas!
★ NEW #Communicable out now! Today is Int'l Women's Day & to honour that we give you the first of a 2-part special on gender dynamics in medicine 🎙️
share.transistor.fm/s/21a9df96
#IDSky #clinmicro #IWD2025 @angelahuttner.bsky.social @erinmccreary.bsky.social @anniejoseph.bsky.social & more
share.transistor.fm/s/21a9df96
#IDSky #clinmicro #IWD2025 @angelahuttner.bsky.social @erinmccreary.bsky.social @anniejoseph.bsky.social & more
Communicable E22: Women & men in medicine: An honest discussion, part 1 | Communicable | Episode 22
In honour of International Women's Day, Communicable releases the first of a two-part special on gender dynamics within the fields of infectious diseases and clinical microbiology. Moderated by Angela...
share.transistor.fm
March 8, 2025 at 5:13 PM
happy #InternationalWomensDay to the endless sea of incredible women out there 👑
thank you @cmicomms.bsky.social @angelahuttner.bsky.social @anniejoseph.bsky.social for the safe space for this important conversation and our allies Nav, Marc, Josh, and Thomas!
thank you @cmicomms.bsky.social @angelahuttner.bsky.social @anniejoseph.bsky.social for the safe space for this important conversation and our allies Nav, Marc, Josh, and Thomas!
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
We can’t forget about our patients! #allergydelabeling can improve #QOL with more work to be done to further support these findings
#antimicrobials2025
#amssky #idsky
@elisemitri.bsky.social
#antimicrobials2025
#amssky #idsky
@elisemitri.bsky.social
February 22, 2025 at 4:18 AM
We can’t forget about our patients! #allergydelabeling can improve #QOL with more work to be done to further support these findings
#antimicrobials2025
#amssky #idsky
@elisemitri.bsky.social
#antimicrobials2025
#amssky #idsky
@elisemitri.bsky.social
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
📝 Here are cliff notes on the new FDA-approved product #Emblaveo
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
Aztreonam-avibactam (Emblaveo)
Aztreonam-avibactam (Emblaveo) photo source pfizer.nl KEY POINTS Aztreonam-avibactam (Emblaveo) is the combination of aztreonam (a monobactam) that interferes with bacterial cell wall synthesis and av...
www.idstewardship.com
February 9, 2025 at 6:52 PM
📝 Here are cliff notes on the new FDA-approved product #Emblaveo
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
www.idstewardship.com/drugs/aztreo...
💠 IV only
💠 Activity vs Ambler Class B metallo-beta-lactamase (MBL) producing gram negative bacteria (e.g., NDM)
💠 Likely will be expensive
💠 Has been approved in Europe since April 2024
#IDsky
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
Breaking news🔥
US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adult patients who have limited or no alternative options #idsky
US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adult patients who have limited or no alternative options #idsky
February 7, 2025 at 8:15 PM
Breaking news🔥
US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adult patients who have limited or no alternative options #idsky
US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adult patients who have limited or no alternative options #idsky
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
2024 was a 🔥 year in ID
🆕💫 @cidjournal.bsky.social
What’s Hot This Year in ID Clinical Science
The review highlights some of the most important trials and clinical trends in infectious diseases over the past year #idsky
academic.oup.com/cid/advance-...
🆕💫 @cidjournal.bsky.social
What’s Hot This Year in ID Clinical Science
The review highlights some of the most important trials and clinical trends in infectious diseases over the past year #idsky
academic.oup.com/cid/advance-...
What’s Hot This Year in ID Clinical Science
This review covers important public health notices and clinical trials covering a broad range of infectious diseases topics from October 2023 to September
academic.oup.com
February 1, 2025 at 9:12 PM
2024 was a 🔥 year in ID
🆕💫 @cidjournal.bsky.social
What’s Hot This Year in ID Clinical Science
The review highlights some of the most important trials and clinical trends in infectious diseases over the past year #idsky
academic.oup.com/cid/advance-...
🆕💫 @cidjournal.bsky.social
What’s Hot This Year in ID Clinical Science
The review highlights some of the most important trials and clinical trends in infectious diseases over the past year #idsky
academic.oup.com/cid/advance-...
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
come join us in beautiful Madison,WI (one of the birthplaces of PK/PD!) for @sidpharm.bsky.social PKPD Workshop, in partnership with our @escmid.bsky.social PKPD study group friends
Register: sidp.org/event-5963379
pharms, physicians, scientists, trainees, etc - ALL WELCOME
#medsky #idsky #amssky
Register: sidp.org/event-5963379
pharms, physicians, scientists, trainees, etc - ALL WELCOME
#medsky #idsky #amssky
January 12, 2025 at 2:24 PM
come join us in beautiful Madison,WI (one of the birthplaces of PK/PD!) for @sidpharm.bsky.social PKPD Workshop, in partnership with our @escmid.bsky.social PKPD study group friends
Register: sidp.org/event-5963379
pharms, physicians, scientists, trainees, etc - ALL WELCOME
#medsky #idsky #amssky
Register: sidp.org/event-5963379
pharms, physicians, scientists, trainees, etc - ALL WELCOME
#medsky #idsky #amssky
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
Happy New Year, @absteward.bsky.social style! 🎉
Kicking off 2025 with this gem:
🆕💫 How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? #idsky #EMIMCC
journals.asm.org/doi/10.1128/...
Kicking off 2025 with this gem:
🆕💫 How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? #idsky #EMIMCC
journals.asm.org/doi/10.1128/...
How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? | Antimicrobial Agents and Chemotherapy
There is a growing body of evidence supporting early transition to oral antibiotic
therapy to complete treatment courses for gram-negative bloodstream infections (GN-BSI)
(1–3). Most available data fo...
journals.asm.org
December 31, 2024 at 7:34 PM
Happy New Year, @absteward.bsky.social style! 🎉
Kicking off 2025 with this gem:
🆕💫 How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? #idsky #EMIMCC
journals.asm.org/doi/10.1128/...
Kicking off 2025 with this gem:
🆕💫 How accurate is ceftriaxone at predicting susceptibility of enterobacterales isolates to oral higher-generation cephalosporins? #idsky #EMIMCC
journals.asm.org/doi/10.1128/...
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
Great to see the CACTUS study in print! authors.elsevier.com/c/1kHGc5E-Uo... Ceftaz-avi vs. Ceftol-tazo for MDR Pseudomonas. Tremendous effort by all involved, and thanks to a great leadership team. The PRECEDENT network is cooking up much more, check it out at www.precedentnetwork.com! #IDsky
December 17, 2024 at 8:30 PM
Great to see the CACTUS study in print! authors.elsevier.com/c/1kHGc5E-Uo... Ceftaz-avi vs. Ceftol-tazo for MDR Pseudomonas. Tremendous effort by all involved, and thanks to a great leadership team. The PRECEDENT network is cooking up much more, check it out at www.precedentnetwork.com! #IDsky
Polling #IDSky! Anyone have experience timing/analyzing sulfonamide peak lvl for pt on sulfadiazine with Nocardiosis (intolerance to TMP/Sulfa)? Seems like time to peak more delayed - time 3-4 hrs (vs 2hr w/ TMP/sulfa)? Anyone aware of PK lit correlating peak w/ efficacy vs tox for sulfadiazine?
December 18, 2024 at 12:04 AM
Polling #IDSky! Anyone have experience timing/analyzing sulfonamide peak lvl for pt on sulfadiazine with Nocardiosis (intolerance to TMP/Sulfa)? Seems like time to peak more delayed - time 3-4 hrs (vs 2hr w/ TMP/sulfa)? Anyone aware of PK lit correlating peak w/ efficacy vs tox for sulfadiazine?
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🔥🔥 NEW 🔥🔥
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Year In Review: Top Infectious Diseases Articles From 2024
In this article a selection of notable peer-reviewed publications from 2024 are provided. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS Article Construction by: Timothy P. Gauthier, Pharm.D....
www.idstewardship.com
December 11, 2024 at 11:47 PM
🔥🔥 NEW 🔥🔥
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Year In Review: Top Infectious Diseases Articles From 2024
Our new post, a great collaboration with my friend
🌟 @idstewardship.bsky.social
1️⃣6️⃣⚡️🆔 RCTs
7️⃣Syst Reviews/Meta
3️⃣🌏Guidelines ✨️Wiki_Guidelines
#idsky #EMIMCC #medsky #utisky
EnJoy
Share plz!
www.idstewardship.com/year-review-...
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🔥 New in ASHE www.cambridge.org/core/journal...
I’d post the summary text but @bsky.app text limits are too restrictive. #IDsky
I’d post the summary text but @bsky.app text limits are too restrictive. #IDsky
December 12, 2024 at 3:11 AM
🔥 New in ASHE www.cambridge.org/core/journal...
I’d post the summary text but @bsky.app text limits are too restrictive. #IDsky
I’d post the summary text but @bsky.app text limits are too restrictive. #IDsky
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
we updated our metronidazole dosing across UPMC system over a year ago based on Sunish's prelim work and now the final evaluation is published! so proud of him!! #idsky #amssky #pharmsky #medsky
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
December 11, 2024 at 1:34 PM
we updated our metronidazole dosing across UPMC system over a year ago based on Sunish's prelim work and now the final evaluation is published! so proud of him!! #idsky #amssky #pharmsky #medsky
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!!
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
December 5, 2024 at 12:52 PM
it’s the happiest Thursday because @sidpharm.bsky.social and the @escmid.bsky.social PK PD study group are bringing back ICAAC (in spirit)!!!!
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Registration will open next week! The Midwest in the summer is magical - come join us!
sidp.org/page-1543694
#idsky #amssky #pharmsky
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🚨📣 @sidpharm.bsky.social the Board and Programs Committee want to hear from you! Please take 2 minutes to fill out the member survey for 2025 planning before Friday: www.cognitoforms.com/SIDP1/_2025S...
December 2, 2024 at 8:16 PM
🚨📣 @sidpharm.bsky.social the Board and Programs Committee want to hear from you! Please take 2 minutes to fill out the member survey for 2025 planning before Friday: www.cognitoforms.com/SIDP1/_2025S...
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
December 2, 2024 at 7:39 PM
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🆕 #Breakpoints Episode: Drs. @annegretemartson.bsky.social, Megan Wimmer, and Evan Clemens join me to discuss all things (Val)ganciclovir!!! #idsky #pharmsky #amssky @sidpharm.bsky.social
🎧 sidp.pinecast.co
🎧 sidp.pinecast.co
November 29, 2024 at 3:47 PM
🆕 #Breakpoints Episode: Drs. @annegretemartson.bsky.social, Megan Wimmer, and Evan Clemens join me to discuss all things (Val)ganciclovir!!! #idsky #pharmsky #amssky @sidpharm.bsky.social
🎧 sidp.pinecast.co
🎧 sidp.pinecast.co
Reposted by Katie Cinnamon, PharmD, BCPS, BCIDP
🆕️🔥Article @thetxidjournal.bsky.social
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases
Table ✨️2: TID ASP opportunities & initiatives
#idsky #medsky #Txid
onlinelibrary.wiley.com/doi/full/10....
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases
Table ✨️2: TID ASP opportunities & initiatives
#idsky #medsky #Txid
onlinelibrary.wiley.com/doi/full/10....
November 25, 2024 at 2:45 PM
🆕️🔥Article @thetxidjournal.bsky.social
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases
Table ✨️2: TID ASP opportunities & initiatives
#idsky #medsky #Txid
onlinelibrary.wiley.com/doi/full/10....
Not Just an Oxymoron: The Utilitarian's Guide to Antimicrobial Stewardship in Transplant Infectious Diseases
Table ✨️2: TID ASP opportunities & initiatives
#idsky #medsky #Txid
onlinelibrary.wiley.com/doi/full/10....